Zeleňáková Adriana, Szűcsová Jaroslava, Nagy Ľuboš, Girman Vladimír, Zeleňák Vladimír, Huntošová Veronika
Institute of Physics, Pavol Jozef Šafárik University in Košice, Park Angelinum 9, 040 01 Košice, Slovakia.
Institute of Chemistry, Pavol Jozef Šafárik University in Košice, Moyzesova 11, 040 01 Košice, Slovakia.
Nanomaterials (Basel). 2021 Apr 1;11(4):901. doi: 10.3390/nano11040901.
In this study, we describe the magnetic and structural properties and cytotoxicity of drug delivery composite (DDC) consisting of hexagonally ordered mesoporous silica, iron oxide magnetic nanoparticles (FeO), and the drug naproxen (Napro). The nonsteroidal anti-inflammatory drug (NSAID) naproxen was adsorbed into the pores of MCM-41 silica after the ultra-small superparamagnetic iron oxide nanoparticles (USPIONs) encapsulation. Our results confirm the suppression of the Brownian relaxation process caused by a "gripping effect" since the rotation of the whole particle encapsulated in the porous system of mesoporous silica was disabled. This behavior was observed for the first time, to the best of our knowledge. Therefore, the dominant relaxation mechanism in powder and liquid form is the Néel process when the rotation of the nanoparticle's magnetic moment is responsible for the relaxation. The in vitro cytotoxicity tests were performed using human glioma U87 MG cells, and the moderate manifestation of cell death, although at high concentrations of studied systems, was observed with fluorescent labeling by AnnexinV/FITC. All our results indicate that the as-prepared MCM-41/Napro/FeO composite has a potential application as a drug nanocarrier for magnetic-targeted drug delivery.
在本研究中,我们描述了由六方有序介孔二氧化硅、氧化铁磁性纳米颗粒(FeO)和药物萘普生(Napro)组成的药物递送复合物(DDC)的磁性、结构性质和细胞毒性。在超小超顺磁性氧化铁纳米颗粒(USPIONs)包封后,非甾体抗炎药(NSAID)萘普生被吸附到MCM-41二氧化硅的孔中。我们的结果证实了由于封装在介孔二氧化硅多孔系统中的整个颗粒的旋转被阻止,“夹持效应”导致布朗弛豫过程受到抑制。据我们所知,这种行为是首次观察到。因此,当纳米颗粒的磁矩旋转导致弛豫时,粉末和液体形式中的主要弛豫机制是奈尔过程。使用人胶质瘤U87 MG细胞进行了体外细胞毒性试验,通过AnnexinV/FITC荧光标记观察到,尽管在高浓度研究体系下,细胞死亡有中度表现。我们所有的结果表明,所制备的MCM-41/Napro/FeO复合物作为磁性靶向药物递送的药物纳米载体具有潜在应用。